Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
FundRx is an early-stage venture capital firm founded in 2015, headquartered in New York City, with additional presences in Austin and Southern California. The firm focuses on investing in innovative healthcare solutions, particularly in the deep health sector. FundRx operates with a unique community model that includes over 1,000 physicians, scientists, and industry leaders as Venture Partners. This extensive network provides critical insights and resources to portfolio companies, enhancing their chances of success in a complex healthcare landscape.
Since its inception, FundRx has established itself as a key player in the healthcare venture capital space, supporting companies that address significant healthcare challenges. The firm has a portfolio of 14 companies, reflecting its commitment to backing visionary founders who are developing groundbreaking technologies. FundRx's approach emphasizes collaboration and mentorship, ensuring that startups receive the guidance they need to navigate the intricacies of the healthcare market.
FundRx invests primarily in early-stage companies within the deep health sector, which encompasses healthcare, biotech, medical devices, and health tech. The firm targets investments at the pre-seed, seed, and seed-plus stages, with check sizes ranging from $250,000 to $1 million per company. FundRx is particularly interested in technologies that enhance drug formulation, chronic disease detection, and healthcare accessibility. Their investment thesis highlights a strong focus on innovations involving artificial intelligence, robotics, and advanced healthcare solutions.
In addition to financial support, FundRx collaborates with co-investors to bolster the growth of startups in its portfolio. The firm seeks to partner with visionary founders who are committed to making a significant impact on health outcomes. FundRx's unique community model allows it to leverage the expertise of its Venture Partners, providing portfolio companies with invaluable insights and mentorship that are crucial for success in the healthcare sector.
FundRx's portfolio includes a diverse range of companies that are making significant strides in the healthcare sector. Notable portfolio companies include:
This portfolio reflects FundRx's commitment to supporting innovative solutions that address pressing healthcare challenges and improve patient outcomes.
Gurdane Bhutani: Co-founder of FundRx, Gurdane has extensive experience in healthcare venture capital and has been instrumental in shaping the firm's investment strategy. His background includes working with various healthcare startups and understanding the intricacies of the healthcare market.
Justin Martin: Co-founder of FundRx, Justin brings a wealth of knowledge in early-stage investments and has a strong track record of supporting healthcare innovations. His expertise lies in identifying promising technologies and guiding founders through the fundraising process.
Zeshan Muhammedi: Co-founder of FundRx, Zeshan has a background in both healthcare and technology, allowing him to bridge the gap between innovation and practical application. He plays a key role in evaluating potential investments and supporting portfolio companies.
To pitch FundRx, founders should use the entrepreneur portal available at fundrx.com/entrepreneurs. It is essential to include a comprehensive deck that outlines the business model, market opportunity, team background, and technology details. FundRx values clarity and depth in presentations, so founders should ensure that their pitch effectively communicates their vision and the potential impact of their solution.
Response times may vary, but founders can expect to hear back within a few weeks after submission. FundRx prefers warm introductions through their network, which can enhance the likelihood of a favorable review.
As of October 2017, FundRx received a growth investment from NRD Capital Management, which has helped bolster its operations and expand its investment capabilities. This investment reflects confidence in FundRx's unique community model and its potential to drive significant advancements in healthcare.
While there have been no recent deal announcements or notable press coverage since then, FundRx continues to maintain an active portfolio of 14 companies, focusing on deep health innovations that address critical healthcare challenges.
What are FundRx's investment criteria?
FundRx focuses on early-stage companies in the deep health sector, particularly those developing technologies that enhance drug formulation, chronic disease detection, and healthcare accessibility. The firm invests at the pre-seed, seed, and seed-plus stages, with check sizes ranging from $250,000 to $1 million.
How can I apply or pitch to FundRx?
Founders can pitch to FundRx through their entrepreneur portal at fundrx.com/entrepreneurs. It is recommended to include a detailed business plan and information about the team and technology.
What makes FundRx different from other venture capital firms?
FundRx distinguishes itself through its unique community model, which includes over 1,000 Venture Partners comprising physicians, scientists, and industry leaders. This network provides critical insights and mentorship to portfolio companies, enhancing their chances of success.
What is FundRx's geographic scope?
FundRx operates globally, supporting startups that address significant healthcare challenges across various regions.
What is FundRx's post-investment involvement like?
FundRx actively engages with its portfolio companies, leveraging its network of Venture Partners to provide mentorship, resources, and insights that help startups navigate the complexities of the healthcare landscape.
What is the typical fund size and check size for FundRx?
FundRx typically invests between $250,000 and $1 million per company, focusing on early-stage investments in the deep health sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.